The prescription drugs market continues to demonstrate robust expansion driven by rising prevalence of chronic diseases and intensified R&D initiatives. With evolving regulatory landscapes and growing demand for personalized medicines, industry players are recalibrating growth strategies to capitalize on emerging market opportunities. This strategic analysis provides an in-depth overview of...